News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioInvent And Immusol, Inc. To Collaborate On Antibody Therapeutic For Macular Degeneration


4/3/2006 5:23:03 PM

SAN DIEGO & LUND, Sweden--(BUSINESS WIRE)--April 3, 2006--BioInvent International AB (SAX:BINV) and Immusol, Inc. announced today a collaboration for the development of a fully human n-CoDeRĀ® antibody for the treatment of age-related macular degeneration (AMD) and other ophthalmic disorders. Macular degeneration, a poorly treated condition, is the most common cause of vision loss in people over 60, affecting 20-25 million people worldwide. It is characterised by abnormal and uncontrolled vessel growth in the eye.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES